{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:55:39Z","timestamp":1786460139649,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This scoping review aims to describe factors in the existing literature that may inform opioid-prescribing decisions for patients with a past or present history of cancer and past or present substance misuse or substance use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Opioids and opioid-related decisions are critical components of cancer care. Most individuals with cancer will experience pain during cancer care, and over half of patients will receive an opioid prescription. Opioid-prescribing decisions require weighing the benefits and harms. The presence of substance misuse or substance use disorder may elevate the risk of opioid-related harms, but there is a lack of consensus on managing patients at this intersection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Inclusion criteria:<\/jats:title>\n                    <jats:p>This review will consider studies that include adult patients with a past or present history of cancer who also have pain and current or historical substance misuse or substance use disorder. The pain may be cancer-related or non-cancer-related. Studies of patients with all types of cancer will be eligible for inclusion, with the exception of non-melanoma skin cancers. Eligible studies will explore factors that inform opioid-prescribing decisions in this patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The review will be conducted according to JBI methodology for scoping reviews. Studies written in English since database inception will be included. The databases to be searched include MEDLINE (Ovid), CINAHL (EBSCO), Embase, APA PsycINFO, and Google Scholar. Eligible studies will undergo data extraction by 2 independent reviewers using a data extraction tool created by the authors. A narrative summary will describe study characteristics, population details, and strategies used to determine appropriate pain management in the patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbies-22-00007","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T04:00:06Z","timestamp":1669003206000},"page":"812-825","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Opioid-prescribing considerations in patients with cancer and substance misuse or substance use disorder: a scoping review protocol"],"prefix":"10.11124","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-8394","authenticated-orcid":false,"given":"Katie Fitzgerald","family":"Jones","sequence":"first","affiliation":[{"name":"William F. Connell School of Nursing, Boston College, Chestnut Hill, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Malinowski","sequence":"additional","affiliation":[{"name":"Write Inscite, LLC, South Salem, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Paice","sequence":"additional","affiliation":[{"name":"Division Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Childers","sequence":"additional","affiliation":[{"name":"Section of Palliative Care and Medical Ethics and Palliative Research Center, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey W.","family":"Bulls","sequence":"additional","affiliation":[{"name":"Section of Palliative Care and Medical Ethics and Palliative Research Center, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeni","family":"Morrison","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Janet","family":"Ho","sequence":"additional","affiliation":[{"name":"University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Alsbrook","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Nugent","sequence":"additional","affiliation":[{"name":"Division of Clinical Psychology, School of Medication at the VA Portland Healthcare System, Portland, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Broglio","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center, Lebanon, NH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Nickels","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Kentucky, Lexington, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Holbein","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology, West Virginia University, Morgantown, WV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsana","family":"Parajuli","sequence":"additional","affiliation":[{"name":"School of Nursing, University of North Carolina at Charlotte, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Merlin","sequence":"additional","affiliation":[{"name":"MBA Section of Palliative Care and Medical Ethics and Palliative Research Center, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4]]},"reference":[{"issue":"3","key":"R1-20250613","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/j.pain.0000000000001773","article-title":"A delicate balance: risks vs benefits of opioids in cancer pain","volume":"161","author":"Paice","year":"2020","journal-title":"Pain"},{"issue":"8","key":"R2-20250613","doi-asserted-by":"crossref","first-page":"e2013605","DOI":"10.1001\/jamanetworkopen.2020.13605","article-title":"National patterns in prescription opioid use and misuse among cancer survivors in the United States","volume":"3","author":"Jairam","year":"2020","journal-title":"JAMA Network Open"},{"issue":"12","key":"R3-20250613","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/cncr.31303","article-title":"Cancer pain management and the opioid crisis in America: how to preserve hard\u2010earned gains in improving the quality of cancer pain management","volume":"124","author":"Paice","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"R4-20250613","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.radonc.2011.09.016","article-title":"Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy","volume":"101","author":"Zenda","year":"2011","journal-title":"Radiother Oncol"},{"issue":"5","key":"R5-20250613","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaoncol.2019.0042","article-title":"US national trends in opioid-related hospitalizations among patients with cancer","volume":"5","author":"Chua","year":"2019","journal-title":"JAMA Oncol"},{"issue":"12","key":"R6-20250613","doi-asserted-by":"crossref","first-page":"e2139968","DOI":"10.1001\/jamanetworkopen.2021.39968","article-title":"Expert panel consensus on management of advanced cancer\u2013related pain in individuals with opioid use disorder","volume":"4","author":"Merlin","year":"2021","journal-title":"JAMA Network Open"},{"issue":"3","key":"R7-20250613","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cncr.33961","article-title":"Approaches to opioid prescribing in cancer survivors: lessons learned from the general literature","volume":"128","author":"Jones","year":"2021","journal-title":"Cancer"},{"issue":"7","key":"R8-20250613","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/1049909119890556","article-title":"Managing opioids, including misuse and addiction, in patients with serious illness in ambulatory palliative care: a qualitative study","volume":"37","author":"Merlin","year":"2020","journal-title":"Am J Hosp Palliat Care"},{"issue":"2","key":"R9-20250613","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpainsymman.2020.08.015","article-title":"Exploring factors associated with long-term opioid therapy in cancer survivors: an integrative review","volume":"61","author":"Jones","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"R10-20250613","doi-asserted-by":"crossref","first-page":"392","DOI":"10.6004\/jnccn.2019.7379","article-title":"Bridging the gap among clinical practice guidelines for pain management in cancer and sickle cell disease","volume":"18","author":"Alyssa","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"R11-20250613","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2018.09.038","article-title":"Mental disorders associated with recent cancer diagnosis: Results from a nationally representative survey","volume":"105","author":"Mallet","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"R12-20250613","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpainsymman.2011.03.010","article-title":"Pain in patients attending a specialist cancer service: prevalence and association with emotional distress","volume":"43","author":"O\u2019Connor","year":"2012","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"R13-20250613","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nrn1914","article-title":"Cancer pain and its impact on diagnosis, survival and quality of life","volume":"7","author":"Mantyh","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"R14-20250613","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1200\/EDBK_180469","article-title":"Pain and opioids in cancer care: benefits, risks, and alternatives","volume":"37","author":"Bennett","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R15-20250613","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/imj.15354","article-title":"Opioids in advanced lung malignancy: a clinical audit of opioid prescription, patient education and safeguarding","volume":"52(10)","author":"Anil","year":"2022","journal-title":"Intern Med J"},{"key":"R16-20250613","doi-asserted-by":"crossref","first-page":"691720","DOI":"10.3389\/fpain.2021.691720","article-title":"Opioid therapy in cancer patients and survivors at risk of addiction, misuse or complex dependency","volume":"2","author":"Pergolizzi","year":"2021","journal-title":"Front Pain Res"},{"issue":"10","key":"R19-20250613","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"7","key":"R20-20250613","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"R21-20250613","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-22-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:33:11Z","timestamp":1786451591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-22-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-22-00007","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}